Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors

被引:163
作者
Missiha, Sharif B. [1 ]
Ostrowski, Mario [1 ]
Heathcote, E. Jenny [1 ]
机构
[1] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
关键词
D O I
10.1053/j.gastro.2008.02.069
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The hepatic complications of chronic hepatitis C (CHC) usually occur only after progression to cirrhosis has taken place. Progression to cirrhosis, however, is extremely variable and depends on a broad set of host and viral factors that modify the rate at which fibrosis develops in a given individual. Despite their inherent limitations, studies of the natural history of CHC have identified several nonmodifiable factors associated with disease progression. These include age at acquisition of infection, sex, and race. More recent reports suggest important roles for host genetic polymorphisms and viral factors. Of greater immediate relevance to patients and their clinicians are the potentially modifiable factors, which include excessive alcohol consumption; smoking (tobacco and marijuana); insulin resistance; and coinfection with hepatitis B virus, human immunodeficiency virus type 1, or schistosomiasis. Unfortunately, to date, there are no reliable predictive models that can accurately estimate the risk of CHC disease progression.
引用
收藏
页码:1699 / 1714
页数:16
相关论文
共 242 条
  • [51] Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
    Enomoto, N
    Sakuma, I
    Asahina, Y
    Kurosaki, M
    Murakami, T
    Yamamoto, C
    Ogura, Y
    Izumi, N
    Marumo, F
    Sato, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) : 77 - 81
  • [52] COMPARISON OF FULL-LENGTH SEQUENCES OF INTERFERON-SENSITIVE AND RESISTANT HEPATITIS-C VIRUS 1B - SENSITIVITY TO INTERFERON IS CONFERRED BY AMINO-ACID SUBSTITUTIONS IN THE NS5A REGION
    ENOMOTO, N
    SAKUMA, I
    ASAHINA, Y
    KUROSAKI, M
    MURAKAMI, T
    YAMAMOTO, C
    IZUMI, N
    MARUMO, F
    SATO, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 224 - 230
  • [53] EYSTER ME, 1994, BLOOD, V84, P1020
  • [54] Low fibrosis progression of recurrent hepatitis C in apolipoprotein E ε4 carriers:: relationship with the blood lipid profile
    Fabris, C
    Toniutto, P
    Bitetto, D
    Minisini, R
    Smirne, C
    Caldato, M
    Pirisi, M
    [J]. LIVER INTERNATIONAL, 2005, 25 (06) : 1128 - 1135
  • [55] Fargion S, 2002, AM J GASTROENTEROL, V97, P1204
  • [56] Hepatitis C - Identifying patients with progressive liver injury
    Feld, JJ
    Liang, TJ
    [J]. HEPATOLOGY, 2006, 43 (02) : S194 - S206
  • [57] European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
    Féray, C
    Caccamo, L
    Alexander, GJM
    Ducot, B
    Gugenheim, J
    Casanovas, T
    Loinaz, C
    Gigou, M
    Burra, P
    Barkholt, L
    Esteban, R
    Bizollon, T
    Lerut, J
    Minello-Franza, A
    Bernard, PH
    Nachbaur, G
    Botta-Fridlund, D
    Bismuth, H
    Schalm, SW
    Samuel, D
    [J]. GASTROENTEROLOGY, 1999, 117 (03) : 619 - 625
  • [58] Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C
    Fishman, S
    Lurie, Y
    Peretz, H
    Morad, T
    Grynberg, E
    Blendis, LM
    Leshno, M
    Brazowski, E
    Rosner, G
    Halpern, Z
    Oren, R
    [J]. LIVER INTERNATIONAL, 2006, 26 (03) : 279 - 284
  • [59] Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
    Fontana, RJ
    Israel, J
    LeClair, P
    Banner, BF
    Tortorelli, K
    Grace, N
    Levine, RA
    Fiarman, G
    Thiim, M
    Tavill, AS
    Bonkovsky, HL
    [J]. HEPATOLOGY, 2000, 31 (03) : 730 - 736
  • [60] Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease
    Foy, E
    Li, K
    Wang, CF
    Sumpter, R
    Ikeda, M
    Lemon, SM
    Gale, M
    [J]. SCIENCE, 2003, 300 (5622) : 1145 - 1148